Humacyte (HUMA) Stock

HUMA Watch

Humacyte

$1.27

$-0.04 -3.17%

1 Min 5 Min 15 Min Hourly Daily Weekly

Assets Gross Profit Revenue Earnings Expenses

Chart Sentiment News Fundamentals About

Tendies

@tendies

2091 Trades 45.6% Winrate 185.6% Avg Gain Avg Gain 5722.1% S&P Beat

Bought HUMA Shares

57d ago • Swung • Bullish

down -39.13% At 3.22, Exited 1.96

I believe now is a prime opportunity to buy HUMA while it's down. With FDA approval and a huge upside potential reflected in analyst targets, I see si... Read More

Exited 50d ago

0 0

Tendies

@tendies

2091 Trades 45.6% Winrate 185.6% Avg Gain Avg Gain 5722.1% S&P Beat

Bought HUMA Shares

79d ago • Swung • Bullish

down -20.64% At 3.73, Exited 2.96

With the commercial launch of Symvess and FDA approval, I believe Humacyte is set for significant growth in 2025. Their new manufacturing patent furth... Read More

Exited 72d ago

0 0

Degenerate

@wsb

2572 Trades 43.7% Winrate 14.3% Avg Gain Avg Gain 453.1% S&P Beat

Bought HUMA Calls

127d ago • Swung • Bullish

down -68.5% At 0.4, Exited 0.13

Contract: 4.50 Strike Call for Jan 17

I just bought 210 calls for HUMA at a $4.50 strike expiring on 1/17. With FDA approval for their SYMVESS and a huge total addressable market, I believ... Read More

Exited 124d ago

0 0

Long

@long_gam...

1012 Trades 45.9% Winrate 15.1% Avg Gain Avg Gain 135.0% S&P Beat

Bought HUMA Shares

149d ago • Swung • Bullish

up 57.65% At 3.49, Exited 5.5

With Humacyte receiving full FDA approval for SYMVESS™, this is a game changer for the company. The new product addresses a critical medical need and ... Read More

Exited 141d ago

0 0